Shiradi likely to be opened for buses in Oct; Rs 250-cr proposal for Charmadi road repair

Jan 30: One positive case of novel coronavirus has been found in Kerala. The student was studying at Wuhan University in China. The patient is stable and is being closely monitored.

This is the first case of coronavirus that has been reported in India.

Until now, there have only been many suspected cases across the country. A total of eight patients, five of them in Mumbai, are under observation in Maharashtra for suspected coronavirus infection. Six patients were already under observation and two more people, who complained of cough and mild fever, symptoms similar to the coronavirus, were put under medical watch on Tuesday evening.

One suspected case each has been reported in Rajasthan and Chandigarh.

Novel coronavirus (nCoV) is a large family of viruses that causes illnesses ranging from the common cold to acute respiratory syndromes. However, the virus that has so far killed 170 people and affected 7,000 in China is a novel strain and not seen before.

It has emerged from a seafood and animal market in Wuhan city and is suspected to have spread to as far as the United States.

According to the World Health Organisation, the common symptoms of the novel coronavirus strain include respiratory symptoms such as fever, cough, shortness of breath and breathing difficulties.

Puttur, June 10: Passengers of a KSRTC bus had a miraculous escape while driver and conductor suffered minor injuries after it fell on a house below 25ft.

Police said that except for some minor injuries to the driver and conductor none of the 21 passengers were hurt.

The bus was bound for Ishwaramangala from Puttur when the mishap took place as the driver lost control over the steering.

The roof and walls of the house on which the bus fell was partially damaged.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.